Pay in 4 interest-free payments of $9.75 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Curr Pharm Des
prevents DNA-TLR9 interaction in vitro and modulates signaling in vivo
Smiles: CC(C1CCN(CC1)S(=O)(=O)CC)N1C2=CC=CC=C2C(C(=O)NCC2=C(C=C(C)NC2=O)OC)=C1C
targeting Akt1
α-Synuclein inhibitor NAB2
RVX-208 - BET Bromodomain Inhibitor. CAS# 1044870-39-4 60428 Curr Pharm DesRVX 208, CAS No. 1044870 39 4, also known as Apabetalone, is a potent inhibitor of BET bromodomains. RVX 208 functions by removing atherosclerotic plaque via reverse cholesterol transport (RCT). RVX 208 increases the production of ApoA I in hepatocytes in vitro, and in vivo in monkeys and humans, which results in increased HDL C, but the molecular target was not previously reported. RVX 208 may be a promising new approach to the treatment of
US$ 79.34
US$ 131.94
US$ 120.44
US$ 116.15
US$ 138.34